Biography
Carin A. Uyl-de Groot studied Health Care Policy and Management at the Erasmus University Rotterdam. From March 1990 onwards she is working at the institute for Medical Technology Assessment/Department of Health Care Policy and Management at the Erasmus Medical Centre Rotterdam. Her research activities are mainly focused on cost-effectiveness analyses of cancer treatments. Quality of life studies are an integral part of these studies. From 1994 she is program leader of cancer studies. Her main interest consists of diagnostics and therapeutic technologies, economic studies linked to clinical studies, modelling studies, cost studies, quality of life studies, methodological issues and implementation studies particularly in the cancer field. She got her PhD in 1995. Since March 2000 she is director of the institute for Medical Technology Assessment. Since November 2005 she has been appointed professor of health technology assessment at the VU University Medical Center in Amsterdam.
Erasmus School of Health Policy & Management
Full professor | Health Technology Assessment (HTA)
- uyl@eshpm.eur.nl
- Room
- J8-35
- Location
- Burg. Oudlaan 50, Rotterdam
More information
Work
- Brenda Leeneman, Nicolas S.H. Xander, W. Edward Fiets, Wouter K. de Jong, Nathalie E.M. Uyl, A. N.Machteld Wymenga, An K.L. Reyners & Carin A. Uyl-de Groot (2024) - Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness - European Journal of Cancer, 202 - doi: 10.1016/j.ejca.2024.114002 - [link]
- M. M.J. Galekop, J. Veldwijk, C. A. Uyl-de Groot & W. K. Redekop (2024) - Preferences and willingness to pay for personalized nutrition interventions: Discrete choice experiments in Europe and the United States - Food Quality and Preference, 113 - doi: 10.1016/j.foodqual.2023.105075 - [link]
- Céline van de Braak, François E.J.A. Willemssen, Rob A. de Man, Aad van der Lugt, Carin A. Uyl-de Groot, Daniel Bos & Roy S. Dwarkasing (2024) - Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study - European radiology experimental, 8 (1) - doi: 10.1186/s41747-024-00432-6 - [link]
- Milanne Maria Johanna Galekop, Josep Maria Del Bas, Philip C. Calder, Carin A. Uyl-De Groot & William Ken Redekop (2024) - A health technology assessment of personalized nutrition interventions using the EUnetHTA HTA Core Model - International Journal of Technology Assessment in Health Care, 40 (1) - doi: 10.1017/S0266462324000060 - [link]
- Ilias Houda, Chris Dickhoff, Carin A. Uyl-de Groot, Ronald A.M. Damhuis, Noemi Reguart, Mariano Provencio, Antonin Levy, Rafal Dziadziuszko, Cecilia Pompili, Massimo Di Maio, Michael Thomas, Alessandro Brunelli, Sanjay Popat, Suresh Senan & Idris Bahce (2024) - Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective - The Lancet Regional Health - Europe, 38 - doi: 10.1016/j.lanepe.2024.100841 - [link]
- Ilias Houda, Chris Dickhoff, Carin A. Uyl-de Groot, Noemi Reguart, Mariano Provencio, Antonin Levy, Rafal Dziadziuszko, Cecilia Pompili, Massimo Di Maio, Michael Thomas, Alessandro Brunelli, Sanjay Popat, Suresh Senan & Idris Bahce (2024) - New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe - The Lancet Regional Health - Europe, 38 - doi: 10.1016/j.lanepe.2024.100840 - [link]
- R. J.S.D. Heine, F. W. Thielen, R. H.J. Mathijssen, R. W.F. van Leeuwen, M. G. Franken & C. A. Uyl-de Groot (2024) - Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab - PLoS ONE, 19 (2 February) - doi: 10.1371/journal.pone.0293264 - [link]
- Katharina Brück, Richard P. Meijer, , Joost L. Boormans, Lambertus A. Kiemeney, J. Alfred Witjes, Lisa M.C. van Hoogstraten, Michiel S. van der Heijden, A. Rogier Donders, Martine Franckena, Carin A. Uyl de Groot, Annemarie M. Leliveld, Katja K.H. Aben & Maarten C.C.M. Hulshof (2024) - Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study - International Journal of Radiation Oncology Biology Physics, 118 (1), 41-49 - doi: 10.1016/j.ijrobp.2023.07.027 - [link]
- Milanne Maria Johanna Galekop, Carin Uyl-de Groot & William Ken Redekop (2023) - Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in Denmark - PharmacoEconomics - Open, 8 (2), 313-331 - doi: 10.1007/s41669-023-00461-8 - [link]
- Martine E.D. Chamuleau, Frank Stenner, Dana A. Chitu, Urban Novak, Monique C. Minnema, Paul Geerts, Wendy B.C. Stevens, Thorsten Zenz, Gustaaf W. van Imhoff, Ka Lung Wu, Astrid M.P. Demandt, Marie Jose Kersten, Wim E. Terpstra, Lidwine W. Tick, Dries Deeren, Eric Van Den Neste, Michael Gregor, Hendrik Veelken, Lara H. Böhmer, Clemens B. Caspar, Pim Mutsaers, Jeannine M. Refos, Robby Sewsaran, Liping Fu, Rianne L. Seefat, Carin A. Uyl-de Groot, Stefan Dirnhofer, Michiel Van Den Brand, Daphne de Jong, Marcel Nijland & Pieternella Lugtenburg (2023) - R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial - The Lancet Haematology, 10 (12), e966-e975 - doi: 10.1016/S2352-3026(23)00279-X - [link]
- Carin Uyl - de Groot, Ken Redekop, Amir Ansaripour, K. Zendehdel, N. Tadayon & F. Sadeghi (2016) - Use of data-mining to perform a real world cost analysis of HER2-positive breast cancer in Iran
Cie Beoordeling Oncologische Middelen
- Start date approval
- July 2022
- End date approval
- July 2025
- Place
- UTRECHT
Gezondheidsraad
- Start date approval
- July 2022
- End date approval
- July 2025
- Place
- DEN HAAG
bestuurslid CPO, Erasmus Medisch Centrum
- Start date approval
- July 2022
- End date approval
- July 2025
- Place
- ONBEKEND
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2023
- Course Code
- GW4555M
Master Thesis Eu-HEM
- Level
- master
- Year Level
- master
- Year
- 2023
- Course Code
- GW4560M
Master Thesis HE
- Year Level
- master, master
- Year
- 2023
- Course Code
- GW4592M
Module Knowledge
- Level
- bachelor 1
- Year Level
- bachelor 1
- Year
- 2023
- Course Code
- GW114K
